Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 50

1.

Topiramate for treating alcohol dependence: a randomized controlled trial.

Johnson BA, Rosenthal N, Capece JA, Wiegand F, Mao L, Beyers K, McKay A, Ait-Daoud N, Anton RF, Ciraulo DA, Kranzler HR, Mann K, O'Malley SS, Swift RM; Topiramate for Alcoholism Advisory Board; Topiramate for Alcoholism Study Group.

JAMA. 2007 Oct 10;298(14):1641-51.

PMID:
17925516
2.

Opioid receptor gene (OPRM1, OPRK1, and OPRD1) variants and response to naltrexone treatment for alcohol dependence: results from the VA Cooperative Study.

Gelernter J, Gueorguieva R, Kranzler HR, Zhang H, Cramer J, Rosenheck R, Krystal JH; VA Cooperative Study #425 Study Group.

Alcohol Clin Exp Res. 2007 Apr;31(4):555-63.

PMID:
17374034
3.

Association of a functional polymorphism in the mu-opioid receptor gene with alcohol response and consumption in male rhesus macaques.

Barr CS, Schwandt M, Lindell SG, Chen SA, Goldman D, Suomi SJ, Higley JD, Heilig M.

Arch Gen Psychiatry. 2007 Mar;64(3):369-76.

PMID:
17339526
4.

A functional polymorphism of the mu-opioid receptor gene (OPRM1) influences cue-induced craving for alcohol in male heavy drinkers.

van den Wildenberg E, Wiers RW, Dessers J, Janssen RG, Lambrichs EH, Smeets HJ, van Breukelen GJ.

Alcohol Clin Exp Res. 2007 Jan;31(1):1-10.

PMID:
17207095
5.
6.

Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial.

Anton RF, O'Malley SS, Ciraulo DA, Cisler RA, Couper D, Donovan DM, Gastfriend DR, Hosking JD, Johnson BA, LoCastro JS, Longabaugh R, Mason BJ, Mattson ME, Miller WR, Pettinati HM, Randall CL, Swift R, Weiss RD, Williams LD, Zweben A; COMBINE Study Research Group.

JAMA. 2006 May 3;295(17):2003-17.

PMID:
16670409
7.

Effect of oral acamprosate on abstinence in patients with alcohol dependence in a double-blind, placebo-controlled trial: the role of patient motivation.

Mason BJ, Goodman AM, Chabac S, Lehert P.

J Psychiatr Res. 2006 Aug;40(5):383-93. Epub 2006 Mar 20.

PMID:
16546214
8.

Association of an Asn40Asp (A118G) polymorphism in the mu-opioid receptor gene with substance dependence: a meta-analysis.

Arias A, Feinn R, Kranzler HR.

Drug Alcohol Depend. 2006 Jul 27;83(3):262-8. Epub 2006 Jan 4.

PMID:
16387451
9.

A microdialysis profile of Met-enkephalin release in the rat nucleus accumbens following alcohol administration.

Marinelli PW, Bai L, Quirion R, Gianoulakis C.

Alcohol Clin Exp Res. 2005 Oct;29(10):1821-8.

PMID:
16269911
10.

Origins, issues and options in the development of the combined behavioral intervention.

Longabaugh R, Zweben A, Locastro JS, Miller WR.

J Stud Alcohol Suppl. 2005 Jul;(15):179-87; discussion 168-9.

PMID:
16223069
11.

A structured approach to medical management: a psychosocial intervention to support pharmacotherapy in the treatment of alcohol dependence.

Pettinati HM, Weiss RD, Dundon W, Miller WR, Donovan D, Ernst DB, Rounsaville BJ.

J Stud Alcohol Suppl. 2005 Jul;(15):170-8; discussion 168-9.

PMID:
16223068
12.

The COMBINE SAFTEE: a structured instrument for collecting adverse events adapted for clinical studies in the alcoholism field.

Johnson BA, Ait-Daoud N, Roache JD.

J Stud Alcohol Suppl. 2005 Jul;(15):157-67; discussion 140.

PMID:
16223067
13.

Rationale for combining acamprosate and naltrexone for treating alcohol dependence.

Mason BJ.

J Stud Alcohol Suppl. 2005 Jul;(15):148-56; discussion 140. Review.

PMID:
16223066
15.

COMBINE genetics study: the pharmacogenetics of alcoholism treatment response: genes and mechanisms.

Goldman D, Oroszi G, O'Malley S, Anton R.

J Stud Alcohol Suppl. 2005 Jul;(15):56-64; discussion 33. Review.

PMID:
16223057
16.

Allelic expression imbalance of human mu opioid receptor (OPRM1) caused by variant A118G.

Zhang Y, Wang D, Johnson AD, Papp AC, Sadée W.

J Biol Chem. 2005 Sep 23;280(38):32618-24. Epub 2005 Jul 26. Erratum in: J Biol Chem. 2005 Nov 18;280(46):38888.

17.

Naltrexone for the treatment of alcoholism: a meta-analysis of randomized controlled trials.

Srisurapanont M, Jarusuraisin N.

Int J Neuropsychopharmacol. 2005 Jun;8(2):267-80.

PMID:
15850502
18.

A polymorphism of the mu-opioid receptor gene (OPRM1) and sensitivity to the effects of alcohol in humans.

Ray LA, Hutchison KE.

Alcohol Clin Exp Res. 2004 Dec;28(12):1789-95.

PMID:
15608594
19.

Association of functional opioid receptor genotypes with alcohol dependence in Koreans.

Kim SG, Kim CM, Kang DH, Kim YJ, Byun WT, Kim SY, Park JM, Kim MJ, Oslin DW.

Alcohol Clin Exp Res. 2004 Jul;28(7):986-90.

PMID:
15252283
20.

Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review.

Bouza C, Angeles M, Muñoz A, Amate JM.

Addiction. 2004 Jul;99(7):811-28. Review. Erratum in: Addiction. 2005 Apr;100(4):573. Magro, Angeles [corrected to Angeles, Magro].

PMID:
15200577

Supplemental Content

Support Center